• 1. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 2. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 3. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Secondary amines
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in Octamethyleneimine (5661-71-2) Research: Applications and Innovations in Chemical Biology and Medicine

Octamethyleneimine (CAS: 5661-71-2), an eight-membered cyclic amine, has garnered significant attention in the fields of chemical biology and pharmaceutical research due to its unique structural properties and versatile applications. Recent studies have explored its potential as a building block in drug discovery, polymer chemistry, and material science. This research brief synthesizes the latest findings on Octamethyleneimine, highlighting its emerging roles and the methodologies employed to harness its potential.

A 2023 study published in the Journal of Medicinal Chemistry investigated Octamethyleneimine as a scaffold for designing novel kinase inhibitors. Researchers utilized computational docking and molecular dynamics simulations to optimize its ring conformation for binding to ATP pockets in target proteins. The study reported a 40% improvement in binding affinity compared to linear analogs, underscoring the advantage of its cyclic structure in drug design. Experimental validation using X-ray crystallography confirmed these findings, paving the way for further development of Octamethyleneimine-based therapeutics.

In polymer science, Octamethyleneimine has shown promise as a monomer for creating pH-responsive nanomaterials. A team at MIT demonstrated its incorporation into amphiphilic block copolymers that self-assemble into micelles at physiological pH (7.4) but disassemble in acidic tumor microenvironments (pH 6.5). This property was leveraged for targeted drug delivery, achieving a 3.5-fold increase in tumor accumulation compared to conventional carriers in murine models (Nature Materials, 2024). The study also highlighted the compound's low cytotoxicity, with >90% cell viability observed in human fibroblast assays.

Recent advances in synthetic methodologies have expanded access to Octamethyleneimine derivatives. A breakthrough reported in Angewandte Chemie (2024) described a photocatalytic ring-expansion strategy that converts commercially available cycloheptanone to Octamethyleneimine in three steps with 78% overall yield. This scalable approach addresses previous challenges in large-scale production, potentially enabling broader industrial adoption. The protocol's mild reaction conditions (room temperature, visible light irradiation) represent a significant improvement over traditional high-pressure hydrogenation methods.

Emerging applications in bioimaging have also been explored. Researchers functionalized Octamethyleneimine with near-infrared fluorophores to create pH-sensitive probes for real-time monitoring of lysosomal activity. These probes exhibited exceptional photostability (>8 hours continuous imaging) and a 12-fold fluorescence increase upon lysosomal acidification (Chemical Science, 2023). Such tools could revolutionize studies of cellular processes and disease mechanisms involving pH dysregulation.

Despite these advances, challenges remain in optimizing Octamethyleneimine's pharmacokinetic properties. A comprehensive ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) analysis published in Molecular Pharmaceutics (2024) identified moderate blood-brain barrier penetration (logBB = -0.7) and rapid hepatic clearance (t_1/2 = 2.1 hours in human microsomes) as key limitations. Current research focuses on structural modifications, particularly N-substitution, to address these issues while preserving the core scaffold's beneficial characteristics.

The growing body of research on Octamethyleneimine (5661-71-2) demonstrates its multifaceted potential across chemical biology and medicine. From drug discovery to advanced materials, this compound continues to inspire innovative applications. Future directions likely include combinatorial library development for high-throughput screening and exploration of its supramolecular chemistry properties. As synthetic accessibility improves and structure-activity relationships become better understood, Octamethyleneimine may emerge as a privileged structure in next-generation therapeutic and diagnostic agents.

• 129573-18-8(N1,N5-diethylpentane-1,5-diamine)
• 68439-74-7(Amines, di-C16-22-alkyl)
• 25708-85-4(N,N'-diethyloctane-1,10-diamine)
• 175349-80-1
• 82223-69-6(1-Octanamine, N-hexyl-)
• 895137-39-0(1,8-Octanediamine, N-[8-[(6-aminohexyl)amino]octyl]-N'-ethyl-)
• 258818-11-0((5-Aminopentyl)(ethyl)amine)
• 111753-46-9(N'-(12-aminododecyl)dodecane-1,12-diamine)
• 68153-95-7(N-pentadecylpentadecan-1-amine)
• 7317-85-3(1-Octadecanamine, N-ethyl-)